KK
MDGL icon

KLP Kapitalforvaltning’s Madrigal Pharmaceuticals MDGL Stock Holding History

KLP Kapitalforvaltning’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Buy
3,360
+120
+4% +$61.5K 0.01% 831
2026
Q1 		$1.7M Hold
3,240
– – 0.01% 775
2025
Q4 		$1.89M Buy
3,240
+240
+8% +$123K 0.01% 741
2025
Q3 		$1.38M Hold
3,000
– – 0.01% 849
2025
Q2 		$908K Buy
3,000
+400
+15% +$119K ﹤0.01% 1037
2025
Q1 		$861K Hold
2,600
– – ﹤0.01% 1009
2024
Q4 		$802K Buy
+2,600
New +$731K ﹤0.01% 1091

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KLP Kapitalforvaltning's MDGL Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Madrigal Pharmaceuticals (MDGL) stake by 3.7% in Q2 2026, buying an estimated $61.5K and bringing the position to 3,360 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #831.

KLP Kapitalforvaltning first reported a position in MDGL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.89M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • KLP Kapitalforvaltning held 3,360 shares of Madrigal Pharmaceuticals worth $1.8M as of Q2 2026.
  • KLP Kapitalforvaltning bought 120 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $61.5K.
  • Madrigal Pharmaceuticals made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #831 holding.
  • KLP Kapitalforvaltning first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Madrigal Pharmaceuticals position peaked at $1.89M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.